Novo Nordisk stabilising down in % as much as the weight loss from the Cagrisema drug disappointment just released (ie: 22.7%) European long only portfolios are all far too 'overweight' this name. no, *you* shut up: - ThreadSky

brokenbanker.bsky.social • 112 days ago

Novo Nordisk stabilising down in % as much as the weight loss from the Cagrisema drug disappointment just released (ie: 22.7%)

European long only portfolios are all far too 'overweight' this name. no, *you* shut up:

1 / 2